SecBot SecBot
8-K ·Filed May 26, 2026

CYPH

CYPHERPUNK TECHNOLOGIES INC.
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001104659-26-066019
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

The delisting risk is removed, which may provide a small near-term sentiment boost. However, with 0% analyst bullishness and no fundamental catalyst, this is a routine compliance update. Monitor for upcoming quarterly results to assess the business trajectory.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CYPH ▼ -7.76% at T+60d
NEUTRAL call -7.76% · α vs SPY -10.48% · entry $1.16 → $1.07
Entry = T+0 close
May 26, 2026
via day close
T+1d
-7.76%
call -7.76% · α -7.77%
$1.07
settled 5mo ago
T+5d
-9.48%
call -9.48% · α -10.57%
$1.05
settled 5mo ago
T+20d
-46.83%
call -46.83% · α -44.88%
$0.6168
settled 4mo ago
T+60d
-7.76%
call -7.76% · α -10.48%
$1.07
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Cypherpunk Technologies received a Nasdaq notice on May 21, 2026, confirming it has regained compliance with the minimum $1.00 bid price requirement, closing a previously disclosed deficiency matter from March 4, 2026. This removes the near-term delisting risk from Nasdaq, but the filing contains no financial data, guidance, or operational updates.

Key Facts

  • Nasdaq notified CYPH on May 21, 2026 that it regained compliance with Listing Rule 5550(a)(2) (minimum bid price).
  • The deficiency period began March 4, 2026 when the stock closed below $1.00 for 30 consecutive business days.
  • No financial results, guidance, or other material operational information was disclosed.
  • The compliance matter is now closed with no further action required.

Financial Impact

No financial data disclosed. Removal of delisting risk is a modest procedural positive but has no quantifiable dollar impact.

Risk Factors

  • Stock price could again fall below $1.00, triggering another deficiency period.
  • No operational or financial improvement was announced—fundamental risks remain unchanged.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-066019
Document: 0001104659-26-066019-index-headers.html0001104659-26-066019
Document: 0001104659-26-066019-index.html0001104659-26-066019
Document: 0001104659-26-066019.txt0001104659-26-066019
9 reports for CYPH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CYPH — sortable, filterable
TypeNow
Sep 25, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$3.31 $2.83▲ +14.50%▲ +14.47%$2.83 (+14.50%)
Sep 22, 2026
4w ago
Institutional Cluster
NEUTRAL ★ 3/10
$3.73 $2.81▼ −24.66%▼ −24.11%$2.83 (−24.13%)
Sep 22, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$3.73 $2.81▼ −24.66%▼ −24.11%$2.83 (−24.13%)
Aug 18, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$0.8054 $2.44▲ +202.96%▲ +204.70%$2.83 (+251.38%)
Aug 12, 2026
10w ago
8-K
MIXED ★ 6/10
$0.6579 $2.20▲ +234.40%▲ +236.30%$2.83 (+330.16%)
May 26, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$1.16 $0.6168▼ −46.83%▼ −44.88%$2.83 (+143.97%)
May 14, 2026
23w ago
8-K
BEARISH ★ 6/10
$1.20 $0.6500▲ +45.83%▲ +44.98%$2.83 (−135.83%)
Apr 10, 2026
28w ago
8-K
NEUTRAL ★ 3/10
$0.9900 $1.10▲ +11.11%▲ +3.38%$2.83 (+185.86%)
Mar 27, 2026
30w ago
144
NEUTRAL ★ 3/10
$0.6570 $0.9250▲ +40.79%▲ +28.05%$2.83 (+330.75%)
Showing 9 of 9

US Market Status

Market Closed — Opens in 2h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 26, 2026